Neuroscience and Pharmacology Meet Law
For more than 25 years, our research in addiction and psychiatric disorders has informed high-stakes decisions. We translate this expertise into clear, reliable guidance for litigation involving drugs of abuse, prescription medications, and neuropsychiatric conditions.
Richard De La Garza, II, Ph.D. is a neuroscientist specializing in the neurobiology of addiction, psychiatric illness, and psychopharmacology, with extensive experience analyzing the mechanisms, safety profiles, and real-world impacts of medications affecting the central nervous system. His academic and professional background includes advanced research on brain chemistry related to addiction, depression, anxiety, and PTSD, as well as extensive work in medication development and testing for drug use disorders. This foundation enables him to synthesize complex scientific literature, evaluate clinical, toxicological and pharmacokinetic data, and provide clear, authoritative opinions on issues involving drug effects, misuse liability, behavioral outcomes, and causation.
Leading Neuropharmacology Consultancy
Services
525 US dollars
1,000 US dollars
Latest Insights
In-Depth Neuropharmacology Expertise
With over 25 years of experience as an expert witness in national litigations, we emphasize our extensive background in psychoactive medications and controlled substances. Our goal is to support legal matters with scientific integrity.
Richard De La Garza, II, Ph.D.
Dr. De La Garza is an addiction neuropharmacologist. Dr. De La Garza has published more than 130 peer-reviewed scientific articles that have been cited more than 6,000 times. He has been funded during the past 25 years by the National Institute on Drug Abuse and the National Cancer Institute.
What Our Clients Say
Expert opinions that make a difference.